Clinical Observation on 32 Cases of Senile Obesity or Overweight with Abnormal Glucose Tolerance Treated by Fufang Cangzhu Decoction

Shi Jun Hu Yanyuan Wang Qinghua

doi:10.13288/j.11-2166/r.2005.01.014

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on 32 Cases of Senile Obesity or Overweight with Abnormal Glucose Tolerance Treated by Fufang Cangzhu Decoction

更新时间：2021-11-20

- Clinical Observation on 32 Cases of Senile Obesity or Overweight with Abnormal Glucose Tolerance Treated by Fufang Cangzhu Decoction
- Journal of Traditional Chinese Medicine Issue 1, Pages: 24-25(2005)
- 作者机构：
  
  1. 华中科技大学同济医学院附属梨园医院中西医结合科
  2. 华中科技大学同济医学院附属梨园医院中西医结合科武汉市武昌区东湖梨园新村1号,430077
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2005.01.014
  CLC： R259
- Published：2005
- 稿件说明：
移动端阅览
[1]石珺,胡衍园,王清华.复方苍术汤治疗老年肥胖或超重合并糖耐量异常32例临床观察[J].中医杂志,2005(01):24-25.

Shi Jun Hu Yanyuan Wang Qinghua. Clinical Observation on 32 Cases of Senile Obesity or Overweight with Abnormal Glucose Tolerance Treated by Fufang Cangzhu Decoction[J]. Journal of Traditional Chinese Medicine2005, (1): 24-25.
[1]石珺,胡衍园,王清华.复方苍术汤治疗老年肥胖或超重合并糖耐量异常32例临床观察[J].中医杂志,2005(01):24-25. DOI： 10.13288/j.11-2166/r.2005.01.014.

Shi Jun Hu Yanyuan Wang Qinghua. Clinical Observation on 32 Cases of Senile Obesity or Overweight with Abnormal Glucose Tolerance Treated by Fufang Cangzhu Decoction[J]. Journal of Traditional Chinese Medicine2005, (1): 24-25. DOI： 10.13288/j.11-2166/r.2005.01.014.

摘要

目的:观察复方苍术汤治疗老年肥胖或超重合并糖耐量异常（IGT）的疗效。方法:以复方苍术汤治疗老年肥胖或超重合并 IGT 患者32例

并与盐酸二甲双胍治疗30例作对照

对治疗前后患者体重、腰围、臀围、腰臀比（WHR）、糖耐量、空腹血清胰岛素水平、血脂的变化进行对比观察。结果:复方苍术汤组治疗后患者的体重、腰围、臀围及 WHR、糖耐量试验的血糖水平、空腹血清胰岛素水平、血脂与治疗前比较明显降低（P<0.01或 P<0.05）

与对照组比较差异无显著性（P>0.05）。结论:复方苍术汤对肥胖或超重合并 IGT 患者的体重、腰围、臀围及 WHR、血糖、空腹血清胰岛素水平、血脂有明显降低作用

可用于老年肥胖或超重合并 IGT 患者的减重及干预治疗。

Abstract

Objective:To observe therapeutic effect of Fufang Cangzhu Decoction on senile obesity or overweight with impaired glucose tolerance（IGT）.Methods:32 cases of senile obesity or overweight with IGT were treated by Fufang Cangzhu Decoction and 32 cases by dimethyldiguanide as controls.Changes of body weight

waist circumference

hip circumference

waist hip circumference ratio（WHR）

glucose tolerance

fast serum insulin and blood lipid before and after treatment were compared.Results:After treatment

body weight

waist circumfereince

hip circumference and WHR

glucose tolerance

blood glucose and fast serum insulin

blood lipids in the Fufang Cangzhu Decoction treatment group decreased significantly（P<0.05 or P<0.01）

with no significant difference as compared with the control group（P>0.05）.Conclusion:Fufang Cangzhu Decoction can obviously decrease body weight

waist circumference

hip circumference and WHR

blood glucose

fast serum insulin

blood lipids in the senile patient of obesity or overweight with abnormal glucose tolerance.

关键词

Keywords

references

查看原文

Views

242

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Current Status and Strategic Recommendations for Randomized Controlled Trials on Functional Dyspepsia-Irritable Bowel Syndrome Comorbidity：from a Real-World Research Perspective

Efficacy and Economic Evaluation of Weishi Qingjin Formula （苇石清金方）in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome：A Multicenter Retrospective Real-World Cohort Study

Challenges and Recommendations for Implementing Key Technologies in Decentralized Clinical Trials of Traditional Chinese Medicine

Effect of Tongbian Decoction （通便汤） on the VAPB-PTPIP51 Complex and Autophagy of Interstitial Cells of Cajal in the Colon of Slow Transit Constipation Model Rats

Research on the Correlation Between "Tiangui （天癸）" and Female Reproductive Genetic Diseases

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰